About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 387 record(s)
Req # A-2021-000899
Any adverse events or reaction reports in connection with Nutricia North America’s product, Neocate.Organization: Health Canada
May 2022
Req # A-2021-001041
Reporting protocols and procedures used when someone reports side-effects or adverse reactions to a radiation-emitting medical device.Organization: Health Canada
May 2022
Req # A-2021-001156
PDF file of the following information: Timeline December 1st 2019 to October 15 2021. The Pfizer Covid-19 Vaccine Ingredient List Provided to Health Canada, any document. The Moderna Covid-19 Vaccine Ingredient List Provided to Health Canada, any document. The Astra Zeneca Covid-19 Vaccine Ingredient List Provided to Health Canada, any document. The Johnson and Johnson Covid-19 Vaccine Ingredient List Provided to Health Canada, any document.Organization: Health Canada
May 2022
Req # A-2021-001318
A screenshot or printout of the database showing communications between Sona Nanotech and Health Canada related to their submission for an Interim Order for the use of its COVID-19 rapid detection, point of care, antigen test. Time period: January 1, 2020 to December 31, 2020.Organization: Health Canada
May 2022
Req # A-2021-001547
ArriveCAN Information Sharing Agreement with Canada Border Services Agency (CBSA).Organization: Health Canada
May 2022
Req # A-2021-001773
The number of rapid tests from the federal government distributed to each province for each month and each type of product since September 2020.Organization: Health Canada
May 2022
Req # A-2021-001837
The Rothmans, Benson & Hedges submission in response to the Health Canada consultation document “New Health-Related Labelling for Tobacco Products” dated October 2018.Organization: Health Canada
May 2022
Req # A-2021-001838
The JTI-Macdonald submission in response to the Health Canada consultation document “New Health-Related Labelling for Tobacco Products” dated October 2018.Organization: Health Canada
May 2022
Req # A-2021-001888
All media agreements and/or contracts regarding Public Health Canada's 11 million "Ripple Effect" advertising campaign as cited in the below media release. https://www.canada.ca/en/public-health/news/2021/05/government-of-canada-launches-new-ripple-effect-advertising-campaign-to-encourage-covid-19-vaccination.html.Organization: Health Canada
May 2022
Req # A-2021-002018
The Screening Acceptance Letter(s) from Health Canada to all & any generic drug manufacturer(s) related to all and any Abbreviated New Drug Submission(s) for the medicinal ingredient risperidone which appear(s) on the list of Generic Drug Submissions Under Review (GSUR).Organization: Health Canada
May 2022